Answers are grounded in this paper and cite their sources.
Conference discusses immunology's role in tumor heterogeneity and new therapeutic strategies, highlighting its clinical impacts.
The "Tumor Immunology Meets Oncology" (TIMO XIX) meeting 2025 reports on the rapidly growing field of basic, but in particular translational tumor immunology thereby providing deeper insights into the heterogeneity of tumors, their microenvironment and clinical relevance. This represents the basis for the development of novel immunotherapeutic strategies and combinatorial therapies.
No takes yet. Share an insight, caveat, or question.
Barbara Seliger (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: